Page last updated: 2024-08-17

methylene blue and Genetic Predisposition

methylene blue has been researched along with Genetic Predisposition in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellien, J; Duflot, T; Filhon, B; Joannidès, R; Lamoureux, F; Marie-Cardine, A; Massy-Guillemant, N; Pereira, T; Verstuyft, C1
Liu, L; Lohman, RJ; Morris, M; O'Brien, TJ1

Other Studies

2 other study(ies) available for methylene blue and Genetic Predisposition

ArticleYear
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
    Fundamental & clinical pharmacology, 2018, Volume: 32, Issue:3

    Topics: Administration, Intravenous; Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Child; Cytochrome P-450 CYP2B6; Female; Genetic Predisposition to Disease; Humans; Ifosfamide; Male; Methylene Blue; Neuroprotective Agents; Osteosarcoma; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Treatment Outcome

2018
Validation of a method for localised microinjection of drugs into thalamic subregions in rats for epilepsy pharmacological studies.
    Journal of neuroscience methods, 2005, Aug-15, Volume: 146, Issue:2

    Topics: Animals; Anticonvulsants; Coloring Agents; Diffusion; Disease Models, Animal; Drug Delivery Systems; Electroencephalography; Epilepsy; Female; Genetic Predisposition to Disease; Intralaminar Thalamic Nuclei; Methylene Blue; Microinjections; Rats; Rats, Mutant Strains; Reproducibility of Results; Stereotaxic Techniques; Thalamus; Ventral Thalamic Nuclei

2005